LEXINGTON, Mass.--(BUSINESS WIRE)--
Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will
present a corporate overview at the Jefferies 2017 Global Healthcare
Conference on June 6, 2017, at 10:30 a.m. ET in New York, NY. In
addition, the Company will participate on the Inflammatory Disease panel
at the JMP Securities Life Sciences Conference on June 20, 2017, at 4:00
p.m. ET in New York, NY.
A live webcast of Concert's presentation at the Jefferies conference may
be accessed in the Investor
section of the Company's website at www.concertpharma.com.
Please log on to the Concert website approximately 15 minutes prior to
the scheduled webcast to ensure adequate time for any software downloads
that may be required. A replay of the webcast will be available on
Concert's website for two weeks following the presentation.
Pharmaceuticals is a clinical stage biopharmaceutical company
focused on applying its DCE
Platform® (deuterated chemical entity platform) to create novel
medicines designed to address unmet patient needs. The Company's
approach starts with approved drugs in which deuterium substitution has
the potential to enhance clinical safety, tolerability or efficacy.
Concert has a broad
pipeline of innovative medicines targeting pulmonary diseases,
including cystic fibrosis, autoimmune and inflammatory diseases and
central nervous systems (CNS) disorders. For more information please
Concert Pharmaceuticals Inc., the CoNCERT Pharmaceuticals Inc. logo and
DCE Platform are registered trademarks of Concert Pharmaceuticals, Inc.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170530005227/en/
Concert Pharmaceuticals, Inc.
Justine E. Koenigsberg, 781-674-5284
Source: Concert Pharmaceuticals, Inc.
News Provided by Acquire Media